These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15544456

  • 1. Immunology of AIDS virus and mycobacterial co-infection.
    Chen ZW.
    Curr HIV Res; 2004 Oct; 2(4):351-5. PubMed ID: 15544456
    [Abstract] [Full Text] [Related]

  • 2. Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian immunodeficiency virus- mycobacterium coinfection.
    Shen Y, Zhou D, Chalifoux L, Shen L, Simon M, Zeng X, Lai X, Li Y, Sehgal P, Letvin NL, Chen ZW.
    Infect Immun; 2002 Feb; 70(2):869-77. PubMed ID: 11796622
    [Abstract] [Full Text] [Related]

  • 3. Clinical latency and reactivation of AIDS-related mycobacterial infections.
    Shen Y, Shen L, Sehgal P, Huang D, Qiu L, Du G, Letvin NL, Chen ZW.
    J Virol; 2004 Dec; 78(24):14023-32. PubMed ID: 15564509
    [Abstract] [Full Text] [Related]

  • 4. Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.
    Zhou D, Shen Y, Chalifoux L, Lee-Parritz D, Simon M, Sehgal PK, Zheng L, Halloran M, Chen ZW.
    J Immunol; 1999 Feb 15; 162(4):2204-16. PubMed ID: 9973496
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of adaptive Vgamma2Vdelta2+ T-cell responses during active mycobacterial coinfection of simian immunodeficiency virus SIVmac-infected monkeys.
    Zhou D, Lai X, Shen Y, Sehgal P, Shen L, Simon M, Qiu L, Huang D, Du GZ, Wang Q, Letvin NL, Chen ZW.
    J Virol; 2003 Mar 15; 77(5):2998-3006. PubMed ID: 12584325
    [Abstract] [Full Text] [Related]

  • 6. Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG.
    Shen Y, Shen L, Sehgal P, Zhou D, Simon M, Miller M, Enimi EA, Henckler B, Chalifoux L, Sehgal N, Gastron M, Letvin NL, Chen ZW.
    J Virol; 2001 Sep 15; 75(18):8690-6. PubMed ID: 11507214
    [Abstract] [Full Text] [Related]

  • 7. Chronic Immune Activation in TB/HIV Co-infection.
    Sharan R, Bucşan AN, Ganatra S, Paiardini M, Mohan M, Mehra S, Khader SA, Kaushal D.
    Trends Microbiol; 2020 Aug 15; 28(8):619-632. PubMed ID: 32417227
    [Abstract] [Full Text] [Related]

  • 8. Development of Vgamma2Vdelta2+ T cell responses during active mycobacterial coinfection of simian immunodeficiency virus-infected macaques requires control of viral infection and immune competence of CD4+ T cells.
    Shen L, Shen Y, Huang D, Qiu L, Sehgal P, Du GZ, Miller MD, Letvin NL, Chen ZW.
    J Infect Dis; 2004 Oct 15; 190(8):1438-47. PubMed ID: 15378436
    [Abstract] [Full Text] [Related]

  • 9. Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection.
    Singh B, Sharan R, Ravichandran G, Escobedo R, Shivanna V, Dick EJ, Hall-Ursone S, Arora G, Alvarez X, Singh DK, Kaushal D, Mehra S.
    JCI Insight; 2024 Jul 02; 9(15):. PubMed ID: 39114981
    [Abstract] [Full Text] [Related]

  • 10. Pre-existing Simian Immunodeficiency Virus Infection Increases Expression of T Cell Markers Associated with Activation during Early Mycobacterium tuberculosis Coinfection and Impairs TNF Responses in Granulomas.
    Larson EC, Ellis-Connell A, Rodgers MA, Balgeman AJ, Moriarty RV, Ameel CL, Baranowski TM, Tomko JA, Causgrove CM, Maiello P, O'Connor SL, Scanga CA.
    J Immunol; 2021 Jul 01; 207(1):175-188. PubMed ID: 34145063
    [Abstract] [Full Text] [Related]

  • 11. An HIV-1 infection-related idiotype/clonotype (1F7) is expressed on antibodies directed to envelope glycoprotein in simian immunodeficiency virus- and chimeric simian/human immunodeficiency virus-infected rhesus monkeys.
    Müller S, Margolin DH, Min G.
    Hybridoma; 1997 Feb 01; 16(1):17-21. PubMed ID: 9085123
    [Abstract] [Full Text] [Related]

  • 12. Nonpathogenic SIV and Pathogenic HIV Infections Associate with Disparate Innate Cytokine Signatures in Response to Mycobacterium bovis BCG.
    Gasper MA, Biswas SP, Fisher BS, Ehnert SC, Sherman DR, Sodora DL.
    PLoS One; 2016 Feb 01; 11(8):e0158149. PubMed ID: 27505158
    [Abstract] [Full Text] [Related]

  • 13. Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys.
    Croix DA, Capuano S, Simpson L, Fallert BA, Fuller CL, Klein EC, Reinhart TA, Murphey-Corb M, Flynn JL.
    AIDS Res Hum Retroviruses; 2000 Nov 20; 16(17):1895-908. PubMed ID: 11118075
    [Abstract] [Full Text] [Related]

  • 14. The levels of DNGR-1 and its ligand-bearing cells were altered after human and simian immunodeficiency virus infection.
    Yao WR, Li D, Yu L, Wang FJ, Xing H, Yang GB.
    Immunol Res; 2017 Aug 20; 65(4):869-879. PubMed ID: 28478499
    [Abstract] [Full Text] [Related]

  • 15. Monkeying around with MAIT Cells: Studying the Role of MAIT Cells in SIV and Mtb Co-Infection.
    Moriarty RV, Ellis AL, O'Connor SL.
    Viruses; 2021 May 08; 13(5):. PubMed ID: 34066765
    [Abstract] [Full Text] [Related]

  • 16. Preexisting Simian Immunodeficiency Virus Infection Increases Susceptibility to Tuberculosis in Mauritian Cynomolgus Macaques.
    Rodgers MA, Ameel C, Ellis-Connell AL, Balgeman AJ, Maiello P, Barry GL, Friedrich TC, Klein E, O'Connor SL, Scanga CA.
    Infect Immun; 2018 Dec 08; 86(12):. PubMed ID: 30224552
    [Abstract] [Full Text] [Related]

  • 17. Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model.
    Sharan R, Ganatra SR, Bucsan AN, Cole J, Singh DK, Alvarez X, Gough M, Alvarez C, Blakley A, Ferdin J, Thippeshappa R, Singh B, Escobedo R, Shivanna V, Dick EJ, Hall-Ursone S, Khader SA, Mehra S, Rengarajan J, Kaushal D.
    J Clin Invest; 2022 Feb 01; 132(3):. PubMed ID: 34855621
    [Abstract] [Full Text] [Related]

  • 18. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
    Dunn CS, Hurtrel B, Beyer C, Gloeckler L, Ledger TN, Moog C, Kieny MP, Mehtali M, Schmitt D, Gut JP, Kirn A, Aubertin AM.
    AIDS Res Hum Retroviruses; 1997 Jul 20; 13(11):913-22. PubMed ID: 9223407
    [Abstract] [Full Text] [Related]

  • 19. [The immunological manifestations and cytological characteristics of infection caused by the simian immunodeficiency virus (SIV) in rhesus monkeys].
    Persidskiĭ IuV, Shcherbinskaia AM, Barshteĭn IuA, Antonenko SV, Marichev IL.
    Tsitol Genet; 1993 Jul 20; 27(6):97-104. PubMed ID: 8066812
    [Abstract] [Full Text] [Related]

  • 20. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN, Chitta S, Hossain MM, Hill L, Bernacky BJ, Baze W, Arlinghaus RB, Sastry KJ.
    Vaccine; 2001 Dec 12; 20(5-6):813-25. PubMed ID: 11738745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.